Feasibility of Implementing Long-Acting Injectable Antiretroviral Therapy to Treat HIV: A Survey of Health Providers from the 13 Countries Participating in the ATLAS-2M Trial.
Document Type
Journal Article
Publication Date
3-1-2021
Journal
AIDS Research and Human Retroviruses
Volume
37
Issue
3
Inclusive Pages
207-213
DOI
10.1089/AID.2020.0208
APA Citation
Kerrigan, D., Murray, M., Sanchez Karver, T., Mantsios, A., Walters, N., Hudson, K., Kaplan-Lewis, E., Pulido, F., Bassa, A., Margolis, D., & Galai, N. (2021). Feasibility of Implementing Long-Acting Injectable Antiretroviral Therapy to Treat HIV: A Survey of Health Providers from the 13 Countries Participating in the ATLAS-2M Trial.. AIDS Research and Human Retroviruses, 37 (3). http://dx.doi.org/10.1089/AID.2020.0208
Peer Reviewed
1
Comments
Epub 2021 Jan 19